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ABSTRACT 
Background: Urinary tract infections are among the most common bacterial infection 
frequently occur in community and hospital environment. Catheter associated urinary tract 
infection is a major health care problem responsible for an enormous aggregate burden of 
morbidity, mortality and increased health care costs. To date, little is known about the type of 
bacterial pathogens and their antimicrobial susceptibility pattern among catheterized and 
noncatheterized UTI patients, especially in the study area. 
Objective: The aim of this study was to assess the bacterial pathogens, antimicrobial 
susceptibility pattern and associated risk factors among catheterized and non-catheterized 
UTI suspected patients at University of Gondar referral hospital. 
Methods:  A hospital based comparative cross sectional study was conducted from February 
to May/2017. A total of 208 (70=catheterized and 138=non-catheterized) clinically UTI 
suspected patients were recruited. After obtaining consent from each study subject, 
sociodemographic and clinical data were collected using pre tested structured questionnaire.   
Bacterial isolation from urine was done following standard bacteriological methods and 
antimicrobial susceptibility pattern was performed using Kirby-Bauer disk diffusion 
technique. Data was analyzed using SPSS version 20 computer software and p-value<0.05 
was considered as statistically significant. 
Results: The overall prevalence of culture confirmed UTI (catheterized = 41.4% and non-
catheterized =17.4%) was 25.5% (95%CI=19.7 to 31.3%). The predominant bacterial isolate 
among catheterized and non-catheterized UTI patients was Klebsiella pneumoniae (21.9%) 
and E. coli (41.67%), respectively. Gram negative isolates were resistant to ampicillin and 
augmentin (100%) whereas, Gram positive isolates were resistant to cotrimoxazole (91%). 
Duration of catheter greater than 2 weeks (OR=18.00; 95%CI, 1.787-81.31) among 
catheterized patients, being female (OR=3.77; 95% CI, 1.30 - 10.1.97; p=0.015) and patients 
with underlying disease (OR=3.26; 95%CI, 1.15 - 9.27; p=0.027) in non-catheterized patients 
were significantly associated with UTI. 
Conclusion: Catheterized patients for more than two weeks and non-catheterized females 
and patients with underlying diseases had significantly higher isolation rates of bacterial 
pathogens. Increasing resistance in pathogens isolated from catheterized UTI patients is 
frustrating. Rational use of antimicrobial agent should be thought of to prevent the 
emergence of multidrug resistance. Also, there is a need to establish standard guidelines on 
the care of catheter for all units in the hospital with a view to preventing nosocomial 
infections associated with the device in patients. 
Key words:  Urinary tract infection, catheter associated urinary tract infection,  
antimicrobial susceptibility, bacterial pathogens, North-west Ethiopia.
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1. INTRODUCTION 
1.1.Back ground 
Urinary tract infections (UTIs) refer to infections occurring along the urinary tract from the 
perinephric fascia to the urethral meatus. It is the colonization, invasion and propagation of 
infectious agents in the urinary tract including upper and lower urinary tract (1, 2). Urinary 
tract infection is caused by the presence and growth of micro-organisms particularly bacterial 
pathogens within the genito-urinary tract system. It is one of the commonest disease mainly 
caused by bacterial pathogens in human worldwide(3).Infection may occur at any part of the 
genitourinary tract, including urethra, bladder, urethers, renal pelvis, or renal parenchyma(4).  
The episode of UTI is classified as lower and upper urinary tract infection according to 
where it occurs: urethritis in urethra, cystitis in bladder, bacteriurias in urine, pyelonephritis 
in kidney and pyelitis in urethers (5). Most of these infections involve the lower urinary tract 
and could be either symptomatic or asymptomatic. Patients are said to have symptomatic 
urinary tract infections if there is significant bacteriuria (≥105cfu/ml) with sign and 
symptoms of acute UTI where as asymptomatic bacteriuria is  the presence of significant 
bacteriuria without the symptoms of an acute urinary tract infection (6). The symptoms 
associated with UTIs include; dysuria (painful urination), polyuria (frequent urination), 
urinary urgency, haematuria, fever and flank pain. Infection in children less than one year 
may show additional symptoms like hypothermia, vomiting, bradycardia and lethargy (7). 
Most UTIs are caused by Gram-negative bacteria like Escherichia coli, Klebsiella spp, 
Proteus mirabilis, Pseudomonas aeruginosa, Acinetobacter spp and Serratia spp. and Gram-
positive bacteria such as Enterococcus spp. and Staphylococcus spp (8). Escherichia coli and 
Staphylococcus saprophyticus cause approximately 80% and 15% of acute UTIs, 
respectively in patients without catheters (9). 
Urinary tract infections have become the most common hospital acquired infections, 
accounting for as many as 35% of nosocomial infections, and they are the second most 
common cause of bacteremia in hospitalized patients (10).   
Nosocomial urinary tract infection is usually associated with catheterization. The indwelling 
urinary catheter is an essential part of modern medical care and a variety of different 
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indwelling urinary catheters are used to monitor the various clinical parameters such as 
urinary tract obstructive lesions like benign prostatic hyperplasia who are awaiting surgery 
(11). Catheter associated urinary tract infection (CAUTI) can lead to such complications as 
prostatitis, epididymitis and orchitis in males, cystitis, pyelonephritis, bacteremia, 
endocarditis, septic arthritis and meningitis in patients (12). The risk of acquiring CAUTI 
depends on the method and duration of catheterization, the quality of catheter care and host 
susceptibility (13).  
Women are three times greater risk for UTI than men because of short, straight anatomy of 
the urethra, and termination of female urethra beneath the labia resulting in colonization by 
colonic Gram-negative bacilli. Also UTIs are much more common in elderly than younger 
individuals due to immunity and frequently occur both in community and hospital 
environments (14). 
The types of micro-organisms associated with CAUTIs have changed over time. Many 
infecting strains isolated from CAUTIs display markedly greater antimicrobial resistance 
than organisms that cause community-acquired UTIs. Catheter associated urinary tract 
infections are caused by a variety of resistant bacteria pathogens, including Escherichia coli, 
Klebsiella species, Proteus species, Enterococci species, Pseudomonas species, Enterobacter 
species and Serratia species. Many of these micro-organisms are part of the patients’ 
endogenous bowel flora but they can also be acquired by cross contamination from hospital 
personnel or by exposure to non sterile equipments (15).  
The emergence of antibiotic-resistant strains is a major therapeutic problem that is 
multifactorial and could be explained by several non exhaustive hypotheses. The influence of 
excessive and/or inappropriate antibiotic use, particularly of broad-spectrum agents 
prescribed empirically has been demonstrated (16).  In vitro drug sensitivity testing in 
Ethiopia showed that both Gram negative and Gram-positive organisms were extremely 
resistant to ampicillin, amoxicillin, and tetracycline (17).  
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1.2. Statement of the problem 
Urinary tract infection is one of the most common bacterial infections encountered in many 
parts of the world and associated with significant morbidity and mortality. It is estimated that 
150 million cases of UTI occur on a global basis per year resulting in more than 4 billion 
pounds (6 billion dollars) in direct health care expenditure (18). Bacterial infections of the 
urinary tract have been reported in the community and the prevalence has been reported in all 
age groups and in both sexes (19, 20). Urinary tract infection is one of the most common 
infectious diseases, and reports showed that nearly 10% of people experience a UTI during 
their lifetime (21). It is estimated that 50-60% of all women after puberty experience at least 
one UTI episode during their lifetime and in 8% of UTI episodes the pathogens may stay 
silent (22).  
Urinary tract infection is the fourth most common type of healthcare-associated infection, 
with an estimated 93,300 UTIs in acute care hospitals in 2011 and account for more than 
12% of infections reported by acute care hospitals (23). Catheter acquired urinary tract 
infection is one of the most common health care acquired infection. 70% to 80% of these 
infections are attributable to the use of an indwelling urethral catheter. Recent prevalence 
surveys reported that urinary catheter is the most common indwelling device, with 17.5% of 
patients in 66 European hospitals having a catheter and 23.6% in 183 US hospitals. The daily 
risk of acquisition of urinary infection varies from 3% to 7% when an indwelling urinary 
catheter remains in place (24, 25).  
Catheter associated urinary tract infections are associated with an excess mortality rate of 23 
deaths per 1,000 inpatients and excess costs of $1,000/case, additional costs per hospital 
acquired infection (26). In 2007 the estimated deaths associated with HAIs in U.S. hospitals 
were 98,987: of these, 13,088 for urinary tract infections (27).  According to WHO report of 
2010 in USA, among the total Incidence of 5–6%; 1.7 million HAI affected patients, Urinary 
Tract Infection accounts 36%; 561,667 episodes and 13,088 deaths (28). A study in Greece 
Athens in 2010 also indicates the incidence of UTI was 7.7% and the incidence density was 
4.09 cases/1000 urinary catheter-days. The mortality rate was also 22.8% among patients 
with CAUTI (29).   
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In Africa countries a study conducted in ICUs of Egypt in 2008 reported that among 757 
patients with existing indwelling urinary catheters, a total of 161 episodes of infection were 
diagnosed, for an overall rate of 15.7 CAUTIs per 1000 catheter days (30). In Ethiopia, 
previous studies indicated high prevalence of hospital acquired infections. A rate of 15% and 
26% for UTI were reported from Addis Ababa (31).  
An estimated 17% to 69% of CAUTI may be preventable with implementation of evidence-
based practices. This means that 380,000 infections and 9,000 deaths related to CAUTI per 
year could be prevented (32).The frequency of UTIs depends on many risk factors such as 
diabetes mellitus, advanced age, urinary tract obstructions, immune-suppression, and 
neurological disorders. Also urinary pathogens vary depending upon age, sex, 
catheterization, hospitalization and previous exposure of antimicrobials (33).  
Antimicrobial drug resistance (AMR) among hospital and community acquired 
microorganisms is a problem both in developing and developed countries. Infections caused 
by resistant bacteria adversely affect treatment outcomes, treatment costs, disease spread and 
duration of illness, posing a serious challenge to the future of chemotherapy (34). Some of 
the economic effects of AMR have been attempted, and the findings are disturbing. Previous 
reports demonstrated that high incidence of antimicrobial resistance (68%) to the commonly 
prescribed antimicrobial agents was observed at Gondar. It was also previously reported that 
the isolated pathogens showed resistance from two to nine antimicrobials. The study 
documented that catheterized patients were 4.4 times at risk to develop UTI caused by drug 
resistant bacteria pathogens. Moreover, the report documented that nosocomial infections 
increased by 2.73 times the risk of UTIs (35).  
Even though there are published information concerning the aetiology and susceptibility 
pattern of community acquired UTIs, data regarding CAUTIs in the study area is sparse. 
Thus, the aim of this study is to investigate the bacterial pathogens and their antimicrobial 
susceptibility patterns among UTI patients with history of catheter compared with non 
catheterised ones at University of Gondar referral hospital.  
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1.3.Literature review 
The distributions of bacteria that cause UTIs are different in different parts of the world. 
Several studies have investigated pathogens of the UTIs and reported a steady increase in the 
level of resistance to commonly used antibiotics, including ampicillin and trimethoprim (36).  
A prospective study conducted in Saudi Arabia in 2011 showed that the prevalence of 
community–acquired and hospital-acquired urinary tract infection was reported 55.3% and 
44.7%, respectively. The majority of the bacteria were isolated from female (78.7%) patients 
but only 21.3% among males. Escherichia coli (48.1 and 43.2%) was the commonest cause 
of UTI in community and nosocomial settings followed by Klebsiella species (19.2%. 
Escherichia coli and Klebsiella species isolates were found to be resistant to ampicillin 
(75.4% and 90%, respectively). Moreover, Klebsiella species (25%) and Proteus mirabilis 
(19%) were less susceptible to nitrofurantoin (37). 
Another study in Kashmir since 2012 documented higher proportions of female patients 
suffering from UTI (84.1%). Escherichia coli was the predominant isolate (53.8%) followed 
by Klebsiella pneumoniae (22.4%) and Pseudomonas aeruginosa (7.6%). The overall 
response to ampicillin by all isolates was less than 15% (38). One cross sectional study from 
Iran b/n 2009 to 2010 reported only 8.06% patients demonstrated positive urine cultures. In 
the same fashion, there were higher numbers of positive cases among females (88.69%) 
compared to males (11.3%). Staphylococcus saprophyticus isolates were the most frequent 
gram positive bacteria, exhibited high resistance to ampicillin, tetracycline and erythromycin 
(92.31%) and high susceptibility to nitrofurantoin and vancomycine (92.3%) (39). 
Another cross sectional study conducted in eastern India in 2012 showed significant 
bacteriuria among 35.9% patients. The commonest organisms isolated were E coli (59.6%) 
followed by Enterococcus spp (14.9%) and Klebsiella species (10.6%). Among catheterized 
subjects apart from E.coli (64%), Klebsiella was found to be commoner (12%) than 
Enterococcus 10%. Most Enterobactereacae showed good response to nitrofurantoin and 
Staphylococcus aureus was responsive to vancomycin (40).  
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A study conducted among patients attended the Intensive Care Unit (ICU) of one Tertiary 
Care Hospital in India in 2014 reported that 20% of the demonstrated significant bacterial 
growth (>105 CFU/ml). The most common uropathogens isolated were Escherichia coli 
(40.0%) followed by Staphylococcus aureus (15.0%), Pseudomonas aeruginosa (5.0%) and 
Enterococcus faecalis (5.0%). Most of the Gram negative bacilli were sensitive to amikacin 
(75.0%) and nitrofurantoin (75.0%), while all Gram positive cocci were sensitive to 
vancomycin. MRSA was detected in 66.6% cases and 25.0% gram negative rods were ESBL 
producers (41).  
In Africa, report from Nigeria in 2012 showed a 62.0% prevalence of bacterial uropathogens 
was isolated from symptomatic UTI patients. The dominant bacterial pathogen was E. coli 
(35.3%) followed by Klebsiella species (13.0%), Proteus species (4.0%), P. aeruginosa 
(2.0%) and S. aureus (8.0%). The antimicrobial susceptibility pattern of gram-negative 
bacteria showed low level of resistance (<60%) against ciprofloxacin, gentamicin and 
amoxicillin-clavulanic acid. However, there were high resistance (>80%) of E. coli to 
ampicillin and Pseudomonas aeruginosa to gentamicin (66.7%) (42).  
In Benin, the prevalence of gram negative bacteria pathogens among catheterized patients 
presented with UTI was reported 79%.  Similar to other study reports, Escherichia coli was 
found the dominant pathogen (63%) followed by Pseudomonas species (11%). The 
prevalence of Staphylococcus aureus was 21% (43). Among patients admitted to the critical 
care unit of a national hospital of Kenya due to urinary tract infections, the prevalence of 
E.coli was 23%. The proportion of Klebsiella species and Enterococcus species were 20% 
and 19% respectively. The report also documented that E.coli had high resistance to 
augmentin (65%), ceftriaxone (44%) and ampicillin (43%). Klebsiella species also 
demonstrated high level of resistance to augmentin (61.8%), gentamicin (47.4%) and 
cefotaxime (39.5%). High level of drug resistance was also observed on Enterococcos 
species which had a 58.3% resistance to ampicillin and 37.5% for gentamicin (44).  
Different reports from different parts of Ethiopia demonstrated the burden of bacterial 
pathogens among patients suffering from UTI. Report from Jima University teaching hospital 
documented a 43.3% and 22.2% significant bacteriuria on catheterized and non catheterized 
UTI patients, respectively. The proportion of Klebsiella species was 33.3% followed by E. 
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coli (27.7%) and Enterobacter species (6%). Gram-negative bacteria isolated in both groups 
showed a high level of resistance (88-100%) to ampicillin and low level of resistance (16-
24%) observed to amikacin, ciprofloxacin, nalidxic acid and nitrofurantoin (45).  
A retrospective study conducted in Addis Ababa demonstrated an overall prevalence of 
urinary tract infection of 23.32 % and the highest prevalence was obtained among age groups 
21-30 years (27.16%). The bacterial pathogens isolated were Escherichia coli (44.62%) 
followed by Klebsella species (16.81%), Coagulase negative Staphylococci species (6.06%) 
and Enterococci species (5.06%).In vitro drug sensitivity testing showed that both gram 
negative and gram-positive organisms were extremely resistant to ampicillin (83.93%), 
amoxicillin (78.87%) and tetracycline (77.75%) (46). A prospective study in Mekelle since 
2007 showed that among 96 catheterized patients, 38/96 (39.5%) developed nosocomial UTI 
where as 12  patients out of the 96 who were catheterized (12.5%) developed community-
acquired UTI (47).  
Bacterial pathogens among UTI patients were analyzed using retrospective data at Dessie 
since 2012. The proportion of E. coli, Pseudomonas species, Proteus species, S. aureus and 
Klebsiella species were 60.29%, 8.68%, 7.79%, 7.35% and 5.88%, respectively. E.coli is 
almost resistant to Ampicillin and tetracycline. Similarly Pseudomonas and proteus species 
were resistant to almost all antibiotics except gentamycin (48). On the other hand a 
prospective study in Dessie at different point in time showed an overall significant 
bacteriuria of 22.7%. Escherichia coli were the dominant isolate (63.6%) followed by 
Klebsiella species (8.5%) and Proteus species (8.2%). The three most frequently isolated 
bacteria had resistance rates of 80.1% - 90% to amoxicillin and tetracycline and sensitivity 
rates of 0 to 25% to nitrofurantoin, ciprofloxacin and gentamicin (49).   
Another study conducted in Bahir Dar by the year 2010 indicates that out of 1254 patients, 
118 (9.4%) developed nosocomial UTIs. E. coli, S.aureus and K. pneumoniae were the most 
predominant isolates. Most bacterial isolates showed high resistance rates (>80%) to 
ampicillin and amoxicillin/clavulanic acid (50). Previous report (2008) from the same area 
showed that from 529 urine specimens, bacterial isolates were found in 160 (30.2%). Of 
these, 116 (72.5%) of the isolates were gram negatives. The overall multiple drug resistance 
was 93.1% and 4.4% were sensitive to all antibiotics tested (51).   
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1.4. Significance of the study 
A urinary tract infection is an infection involving any part of the urinary system, including 
urethra, bladder, ureter and kidney (4). UTIs are the most common type of health care-
associated infection. Among UTIs acquired in hospitals, approximately 70 to 80 % are 
associated with a urinary catheter, which is a tube inserted into the bladder through the 
urethra to drain urine (25). Catheterization is a frequent procedure performed for patients 
with urinary tract obstructive lesions such as benign prostatic hyperplasia who are awaiting 
surgery and also as a routine in the management of unconscious patients to monitor their 
urine output (11). The most important risk factor for developing a catheter-associated UTI is 
prolonged use of the urinary catheter (13). 
 This study provides information about the burden of bacterial pathogens, antimicrobial 
susceptibility pattern and associated risk factors among UTI suspected patients who used 
catheters compared with non-catheterized once. Even though there are published information 
concerning the aetiology and susceptibility pattern of community acquired and hospital 
acquired UTIs, local data regarding CAUTIs are sparse at University of Gondar referral 
hospital in particular and other parts of Ethiopia in general. Therefore, the present study 
investigates the bacterial pathogens and their antimicrobial susceptibility pattern among UTI 
patients with history of catheter compared with non-catheterized ones at University of 
Gondar referral hospital. This also provides evidences for the level of control and calls for 
concerted efforts at all levels including regulatory bodies and the public healthcare providers 
for better management of catheter associated UTIs. This study is also important for clinician 
in order to facilitate the empiric treatment of UTI patients where culture and drug 
susceptibility test is impossible. In addition to these, it also used as base line data to conduct 
further studies.  
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2. OBJECTIVES 
2.1. General objective 
➢ The overall aim of this study was to assess the bacterial pathogens, their antimicrobial 
susceptibility pattern and associated risk factors among catheterized UTI suspected 
patients compared with non-catheterized ones. 
2.2. Specific objectives 
⇒To identify bacterial pathogens among UTI patients.   
⇒To compare the prevalence of bacterial pathogens between catheterized and non-
catheterized UTI patients. 
⇒To determine the drug susceptibility patterns of bacterial pathogens isolated from UTI 
patients.  
⇒To compare the drug susceptibility pattern of bacterial pathogens isolated from 
catheterized versus non-catheterized UTI patients. 
⇒To identify risk factors associated with UTIs. 
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3. MATERIALS AND METHODS 
3.1. Study area 
The study was conducted in University of Gondar referral Hospital located in Gondar town 
which is located 747 km from the capital city of the country, Addis Ababa and 182 km far 
from Bahir Dar which is the capital city of the Amhara regional state. According to the recent 
administration, the town has 12 sub cities which consist of 21 kebeles. Gondar is one of the 
ancient and densely populated towns in Ethiopia. Its astronomical location is 12°45′ north 
latitude and 37°45′ east longitudes with an elevation of 2,160 meters above sea level. 
According to the 2007 population and housing census result of Ethiopia, the town had total 
population of 206,987 (98,085 males and 108,902 females). In Gondar town there is one 
referral hospital, 8 health centres, and 15 private clinics serving the population. University of 
Gondar referral Hospital is the only referral hospital in the town which serves for 5 million 
population with 1000 beds and different wards. The hospital consists of an operating room, 
intensive care unit (ICU), fistula center, 13 different wards and outpatient departments. 
3.2. Study design and period 
A Hospital based comparative cross-sectional prospective study was conducted from 
February to May, 2017 at University of Gondar referral hospital. 
3.3. Population 
3.3.1. Source population  
The source population were all patients seeking health service at University of Gondar 
referral hospital during the study period. 
3.3.2. Study population 
The study population were all patients suspected of UTI irrespective of catheter use seeking 
health service at University of Gondar referral hospital with in the study period. 
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3.4. Inclusion and exclusion criteria  
3.4.1. Inclusion criteria 
All patients with sign and symptoms of UTIs seeking health service at the University of 
Gondar referral hospital and who are volunteer to participate was included in the study.  
3.4.2. Exclusion criteria 
Patients with UTIs but treated with antimicrobials within the previous 14 days, those patients 
catheterized for less than 48 hours during the specimen collection time and catheterized 
patients with symptoms of UTI before catheterization were excluded from this study. 
3.5. Study Variables 
3.5.1. Dependent variable 
• The prevalence of bacterial pathogens and their antimicrobial susceptibility pattern. 
3.5.2. Independent variables 
Age, sex, residence, marital status, occupation, patient setting, pregnancy, history of previous 
UTI, history of previous catheterization, duration of catheterization, history of underlying 
disease such as HIV and diabetics. 
3.6.Sample size determination and sampling technique 
3.6.1. Sample size 
Sample size was determined by using EPI version-7 statistical soft ware package where P1 
(prevalence of UTI among catheterized study subjects) found 43.3%, P2 (prevalence of UTI 
in non catheterized study subjects) found 22.2 % (45). At 95% confidence interval and power 
of test being 80%, n1 (number of catheterized study subjects), n2 (number of non-
catheterized study subjects) =1: 2 
Then n1i =63 and n2i =126, Ni =63+126 = 189 
By considering a 10% non response rate NF = Ni+10% of Ni =189+19 =208 (N1f =70 & N2f 
=138) 
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3.6.2. Sampling technique 
Patients with symptoms of UTIs were consecutively recruited by convenient sampling 
technique and included in the study until the required sample size was obtained for each 
category. 
3.7.Definition of terms  
Catheter associated urinary tract infection (CAUTI): is a type of infection resulted up on 
the use of indwelling urinary catheter is in place for >2 calendar days on the date of event.  
Indwelling catheter: A drainage tube that is inserted into the urinary bladder through the 
urethra, is left in place, and is connected to a drainage bag. 
Non-CAUTI:  Patient did not have a urinary catheter in place on the date of event nor the 
day before the date of UTI. 
Mid-stream urine specimen: a specimen obtained from the middle part of urine flow. 
Multidrug resistance (MDR): It is defined as non-susceptibility to at least one agent in 
three or more antimicrobial categories. 
Underlying disease: a disease that cause another issue or disease 
3.8. Data collection 
3.8.1. Socio demographic and clinical data collection 
After taking written informed consent, socio-demographic characteristics, clinical data and 
associated risk factors were collected by trained nurse using pretested structured and 
standardized questionnaire guided interview. 
3.8.2. Urine sample collection  
A freshly voided clean catch midstream urine samples (10-20 ml) was collected from non 
catheterized UTI suspected patients in a wide mouth sterile container with screw cap tops 
after cleansing the genitals with soap and water. Catheter urine specimens (10-20ml) from 
catheterized patients was also collected from the distal edge of the catheter tube (after 
cleaning with an antiseptic) using a sterile needle and syringe into sterile urine container. The 
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urine specimens were then delivered to teaching microbiology laboratory immediately and 
processed within two hour. 
3.8.3. Sample processing 
A. Culture and identification  
Urine specimens obtained from both groups were inoculated on CLED media using 
calibrated loop (0.001ml). Cultures were incubated in aerobic atmosphere at 37oC for 24 
hours. The growth of bacterial pathogens was inspected visually and graded for the presence 
of significant bacteriuria. A significant bacteriuria is defined as colony count > 105 cfu/ml for 
mid stream urine and > 102 cfu/ml for catheter urine sample obtained from catheterized 
patients. Inoculated culture media demonstrated as a significant bacteriuria was sub-cultured 
on Blood agar plate and MacConkey agar plate and incubated for further 24 hours.  
All positive cultures were further identified by their colony characteristics appearance on the 
media, Gram-staining reaction and confirmed by the pattern of biochemical reactions using 
standard procedures. Gram negative bacteria were identified by indole production, H2S 
production in TSI/KIA agar, citrate utilization, motility test, urease test, oxidase, 
carbohydrate utilization test, gas production, sugar fermentation and others. For gram 
positive bacteria coagulase test, novobiacin test, catalase other tests were used for species 
identification (52). 
B. Antimicrobial susceptibility testing  
Antimicrobial susceptibility testing was carried out on each identified organism by Kery 
bauer disc diffusion method on Muller Hinton agar (MHA). After a pure culture was 
obtained, a loop full of bacteria was taken from a colony and was transferred to a tube 
containing 5ml sterile normal saline (0.85% NaCl) and mixed gently until it formed a 
homogenous suspension. The turbidity of the suspension was determined in comparison with 
0.5 McFarland standards. A sterile swab was dipped in to the suspension and excess 
suspension was removed by pressing the swab against the wall of the tube. The swab was 
used to distribute the bacteria suspension evenly over the entire surface of MHA. The 
inoculated plates were left at room temperature for 3-5 minutes until it dry. The 
antimicrobial impregnated disks were placed with sterile forceps on the agar surface at least 
24mm away from each other to avoid the overlapping zone of inhibition. After placing the 
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disk the plate was allowed to stand for 30 minutes to dissolve the antibiotic in the media. 
Then, the plates were inverted and incubated at 37∘C for 18-24 hrs and were read for the 
diameter of zone of inhibition by using a ruler. 
Grades of susceptibility pattern were recognized as sensitive, intermediate, and resistant by 
comparison of zone of inhibition as indicated in the manufacturer’s guide. Intermediate 
results were few in number and therefore were considered as resistant for convenience. 
The antimicrobial agents tested were obtained from Oxoid (UK) in the following 
concentrations: Amikacin (30 μg), Ampicillin (10μg), Amoxicillin-clavulanic acid (20/10 
μg), Ceftriaxone (30 μg), Ciprofloxacin (5 μg), Nitrofurantoin (30 μg), Nalidixic acid (30 μg, 
Cefepime (30 μg), Cefexime (5 μg), Piperacillin (100 μg), Ceftazidime (30 μg), Gentamycin 
(10 μg) and Norfloxacin (5 μg) for Gram negative bacteria. Whereas, Erythromycin (10 μg), 
Penicillin (30 μg), Tetracycline (30 μg), Vancomycine (30 μg), Cotrimoxazole (75 μg) and 
Cefoxitine (30 μg), Nitrofurantoin (300 μg) and Norfloxacin (10%) were for gram positive 
bacteria. The results were interpreted according to the most recent version of the National 
Committee for Clinical Laboratory Standards (NCCLS, 2017) (52, 53). 
3.9. Quality control 
 The reliability of the study findings was guaranteed by implementing Quality Control (QC) 
measures throughout the whole process of the laboratory work. All materials, equipment, 
reagents and procedures were adequately controlled. Pre-analytical, analytical and post-
analytical stages of quality assurance and Standard Operating Procedures (SOPs) were 
strictly followed. Pre-tested structured questionnaire guided interview was used for data 
collection on socio-demographic characteristics, clinical data and associated risk factors. The 
validity and completeness of the questionnaire was daily checked by the principal 
investigator. 
Sterility of culture media was checked by incubating 5% of the batch at 35-37OC overnight 
and was evaluated for possible contamination. The standard reference bacteria strains such as 
S aureus (ATCC25923) P. aeruginosa (ATCC-27853) and E. coli (ATCC-25922) was tested 
weekly as controls on the biochemical tests and agar plates including Mueller Hinton agar 
with antimicrobial discs to assure testing performance of the potency of antimicrobial discs. 
To standardize the inoculums density of bacterial suspension for the susceptibility test, 0.5 
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McFarland standard was used (52, 53). More over the whole procedure and result 
interpretation were cross checked by senior laboratory professionals.  
3.10.  Data analysis  
Data were checked for completeness, cleaned manually, entered and analyzed using SPSS 
version 20 computer software. Frequencies and cross tabulations were used to summarize 
descriptive statistics. Odd ratio and adjusted odds ratio at 95% confidence interval were used 
to interpret the strength of association. Chi-square test, bivariate and multivariate logistic 
regressions were employed to assess the association between outcome and explanatory 
variables. p-values < 0.05 were considered statistically significant. 
3.11. Ethical considerations 
Ethical clearance was obtained from University of Gondar, School of biomedical and 
laboratory sciences ethical review committee and official letter of co-operations were 
provided to Gondar referral hospital prior to data collection. Written informed consent/assent 
was obtained from study participants, guardians or caretakers of children after explaining the 
purpose and objective of the study. Any patient who is not willing to participate in the study 
would not be forced to participate. They were informed that all data and sample obtained 
from them was kept confidential by using codes instead of any personal identifiers and is 
meant only for the purpose of the study. The laboratory results from the study participant 
were communicated to their physicians for appropriate treatment. 
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4. RESULTS 
4.1. Socio-demographic characteristics of study participants 
A total of 208 study subjects (70 catheterized and 138 noncatheterized) patients suspected of 
UTI were included in the study. The mean (SD) age of catheterized and non-catheterized UTI 
patients were 54.6 ± 21.7 years and 35.9 ± 15.1 years, respectively (range from 10 to 95 
years and 10 to 80 years, respectively). There was male preponderance 39 (55.7%) in 
catheterized UTI patients as compared to non-catheterized patients where the majority 76 
(55.1%) were females. Among the study participants, 109 (52%) lived in rural areas, of 
whom 94 (45%) were farmers. Data on the educational and marital status also demonstrated 
that 100(48%) were unable to write and read and 136(66%) were married (Table1). 
4.2. Major clinical features observed among UTI patients  
Among the presenting clinical features for catheterized UTI suspected patients, fever, flank 
pain and suprapubic pain were reported in 46(65.7%), 44(62.9%), and 39(55.7%) 
respectively. Tenderness and dysuria were also reported in 36(51.4%) and 18(25.7%) 
respectively whereas in noncatheterized UTI suspected patients, flank pain 96(69.5%), 
suprapubic pain 89(64.5%), frequency 76(55%) and fever 64(46.4%) were complained by 
study subjects. Moreover, dysuria 46 (33.3%), tenderness 35 (25.4%) and urgency 4(2.9%) 
were also reported (Table-2).  
Culture positivity of urine culture was much higher for catheterized UTI suspected patients 
who presented with dysuria (AOR=13.42, 95% CI= 2.771-65.072) and flank pain 
(AOR=6.895, 95% CI= 1.613-29.481). On the other hand, urine culture among non-
catheterized UTI suspected patients had higher odds of culture positivity among patients 
presented with dysuria (AOR=3.45, 95%CI=1.214-9.786), suprapubic pain (AOR=4.78, 
CI=1.354-16.864) and tenderness (AOR=7.00, CI=2.436-20.093) as compared to their 
counterparts.   
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4.3. Prevalence of significant bacteriuria among catheterized and non-catheterized 
patients 
Culture result of the present study showed that a total of 53 patients (25.5%) (95%CI=19.7-
31.3) suspected for UTI demonstrated significant bacteriuria. Significantly, higher prevalence 
of significant bacteriuria was observed among catheterized patients 29/70 (41.43%) 
compared with non-catheterized cases 24/138 (17.40 %) (p<0.05). The occurrence of 
significant bacteriuria among catheterized UTI suspected patients were 3 times more likely 
[AOR=3.36, 95% CI= (1.75, 6.42)] as compared to non catheterized suspected patients 
(Table 3).   
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Table 1: Socio demographic characteristics of catheterized and non-catheterized UTI 
patients at University of Gondar Referral Hospital, February to May/2017. 
 
Characteristics 
                        Catheterization status 
Catheterized n (%) Non-catheterized n (%)              Total n (%) 
Sex    
Male 39 (55.7) 62 (44.9) 93 (45) 
Female 31 (44.3) 76 (55.1) 115 (55) 
Total  70 (100) 138 (100) 208 (100) 
Age     
<15 2 (2.9) 3 (2.2) 5 (2.4) 
15-24 3 (4.3) 27 (19.6) 30 (14.4) 
25-34 11(15.7) 50 (36.2) 61 (29.40 
35-45 11(15.7) 25 (18.1) 36 (17.3) 
>45 43 (61.4) 33 (23.9) 76 (36.5) 
Total  70 (100) 138 (100) 208 (100) 
Residence    
Rural 44 (62.9) 65 (47.1) 109 (52) 
Urban 26 (37.1) 73 (52.9) 99 (48) 
Total  70 (100) 138 (100) 208 (100) 
Marital status    
Married 43 (61.4) 93 (67.4) 136 (66) 
Single 5 (7.1) 24 (17.4) 29 (14) 
Divorced 5 (7.1) 6 (4.3) 11 (5) 
Widowed 17 (24.3) 15 (10.9) 32 (15) 
Total No (%) 70 (100) 138 (100) 208 (100) 
Educational status    
Unable to write and read 41(58.6) 59 (42.8) 100 (48) 
Read and write only            10 (14.3) 10 (7.2) 20 (10) 
Primary 8 (11.4) 22 (15.9) 30 (14) 
Secondary 8 (11.4) 30 (21.7) 38 (18) 
College and above 3 (4.3) 17 (12.3) 20 (10) 
Total No (%) 70 (100) 138 (100) 208 (100) 
Occupation    
Civil servant 5 (7.1) 23 (16.7) 28 (13.5) 
Merchant 9 (12.9) 20 (14.5) 29 (14) 
Farmer 39 (55.7) 55 (39.9) 94 (45) 
Housewife 9 (12.9) 17 (12.3) 26 (12.5) 
Self employer 4 (5.7) 9 (6.5) 13 (6.3) 
Student 4 (5.7) 14 (10.1) 18 (8.7) 
Total No (%) 70 (100) 138 (100) 208 (100) 
  Patient setting    
  Outpatient 0(0) 128 (92.8) 128 (61.5) 
  Inpatient 70 (100) 10 (7.2) 80 (38.5) 
 Total No (%) 70 (100) 138 (100) 208 (100) 
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Table 2: Association of clinical features with UTI among catheterized and non-catheterized patients at University of Gondar 
Referral Hospital, February to May/2017. 
 Catheterized patients Non-catheterized patients 
 Significant Bacteriuria Significant Bacteriuria 
clinical 
features 
Pos  
n (%) 
Neg  
n (%) 
COR AOR (95%CI) P-
value 
Pos 
 n(%) 
Neg  
n(%) 
COR AOR (95%CI) P-value 
Fever           No 11 (45.8) 13 (54.2) 1   9 (12.2) 65 (87.8) 1 1  
                    Yes 18 (39.1) 28 (60.9) 0.760   15 (23.4) 49 (76.6) 2.211* 2.616 (0.948-7.217) 0.63 
Dysuria        No         16 (30.8) 36 (69.2) 1 1  12 (13) 80 (87) 1 1  
                    Yes 13 (72.2) 5 (27.8) 5.850* 13.427 (2.771-65.072) 0.001* 12 (26.1) 34 (73.9) 2.353* 3.446 (1.214-9.786) 0.020* 
Flank           No 
pain  
8 (30.8) 18 (69.2) 1 1  2 (6.2) 30 (93.8) 1 1  
                    Yes    21 (47.7) 23 (52.3) 2.054* 6.895 (1.613-29.481) 0.009* 22 (20.8) 84 (79.2) 1.357   
Suprapubic No 
pain  
9 (29) 22 (71) 1 1  4 (8.2) 45 (91.8) 1 1  
                    Yes 20 (51.3) 19 (48.7) 2.573* 3.225 (0.967-10.755) 0.057 20 (22.5) 69 (87.5) 3.261* 4.778(1.354-16.864) 0.015* 
Tenderness  No 10 (29.4) 24 (70.6) 1 1  9 (8.7) 94 (91.3) 1 1  
                    Yes 19 (57.8) 17 (42.2) 2.682* 2.914 (0.892-9.517) 0.077 15 (42.9) 20 (57.1) 5.555* 6.997(2.436-20.093) 0.000* 
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Table 3: Comparison of the prevalence of significant bacteriuria among catheterized 
and non-catheterized patients at University of Gondar Referral Hospital, February to 
May/2017. 
Catheterization 
status 
Presence of significant bacteriuria 
 Positive n (%) Negative n (%) Total n (%) OR   95%CI P-
value 
catheterized 29 (41.43) 41 (58.57) 70(33.7) 3.360 1.753-6.423 0.000 
Non-
catheterized 
24 (17.40) 114 (82.60) 138 (66.3) 1 - - 
Total No (%) 53(25.48) 155(74.42) 208(100)    
 
4.4. Prevalence of uropathogenic bacterial isolates 
A total of 56 different types of bacterial pathogens were identified among patients suspected 
for UTI. Of these, 25/56 (45%) were from non-catheterized and 31/56 (55%) from 
catheterized UTI patients respectively. More than one bacteria (mixed type) were isolated in 
both noncatheterized and catheterized groups in the proportions of 1/24(4%) and 2/29(7%) 
respectively. Gram negative bacteria were commonly isolated, 32 (57%) than the Gram 
positive bacterial spps 24 (43%). E. coli 12/56(21.4%) was the most commonly isolated 
bacteria among UTI suspected patients irrespective of catheter use followed by Coagulase 
negative staphylococcus spp 11(19.6%), Klebsiella pneumoniae 9 (16.1%), S.aureus 
9(16.1%), Enterococcus spp 4(7.1%) and Serratia spp 3(35.4%).  
The most frequently isolated bacterial species from non-catheterized patients was E.coli 10 
(40%) followed by Coagulase negative staphylococcus spp which accounts 6(24%). Among 
catheterized patients, Klebsiella pneumoniae and S.aureus were found to be the most 
frequently isolated pathogens 7(22.6%) and 6(19.4%), respectively. Among the bacterial 
isolate, Proteus mirabilis, Pseudomonas aeruginosa, Enterobacter species and Citrobacter 
species were isolated only from catheterized patients.  Isolation of E. coli was significantly 
more frequent in non-catheterized (10/12, 83.3 %) than in catheterized (2/12, 16.7%) (X2= 
9.3, p-value=0.002). On the other hand, all 1(100%) of Proteus mirabilis, 2(100%) 
Pseudomonas aeruginosa, 3(100%) Enterobacter species and 2 (100%) Citrobacter species; 
and the majority (7/9, 77.8%) of Klebsiella pneumoniae and S.aureus (6/9, 66.7%), though 
statistically insignificant, were isolated from catheterized patients (Table 4). 
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Table 4: The proportion of Gram negative and Gram negative bacterial pathogens 
among catheterized and non-catheterized UTI patients at University of Gondar 
Referral Hospital, February to May/2017. 
 
Bacterial isolate 
 
                 Catheterization status 
Catheterized 
No (%) 
Non catheterized 
No (%) 
Total 
No (%) 
X2 
 
P-
value 
 
E.coli 2 (16.7) 10 (83.3) 12 (21.4) 9.251 0.002* 
K.pneumonia 7 (77.8) 2 (22.2) 9 (16) 2.181 0.140 
P.aeruginosa 2 (100) 0 (0) 2 (3.6) 1.673 0.196 
P.mirabilis 1 (100) 0 (0) 1 (1.8) 0.821 0.365 
Enterobacter spps 3 (100) 0 (0) 3 (5.4) 2.556 0.110 
Citrobacter spps 2 (100) 0 (0) 2 (3.6) 1.673 0.196 
Serratia spps 1 (33.3) 2 (66.7) 3 (5.4) 0.622 0.430 
S.aureus 6 (66.7) 3 (33.3) 9 (16.1) 0.555 0.456 
Enterococcus spps 2 (50) 2 (50) 4 (7.1) 0.50 0.823 
CONS 5 (45.5) 6 (54.5) 11 (19.6) 0.543 0.461 
Total No (%) 31 (100) 25 (100) 56 (100)   
 
4.5. Association of risk factors with bacteria caused UTI 
In this study sex, age, duration of the application of catheter, previous history of UTI, 
previous history of catheterization, history of underlying diseases, pregnancy and patient 
setting were used as potential risk factors for UTI. Among catheterized patients, multivariate 
regression analysis showed no statistically significant association between the risk factors 
and CAUTI except the duration of application of catheter.   
Data showed that catheterized patients who had duration of catheterization >2 weeks were 
about 18 times [p=0.014, AOR=18.00, 95%CI= (1.787-81.31)] more likely to develop UTI 
than those who had duration of catheterization with 3days. Even though statistically 
insignificant, a bivariate analysis showed that risk of developing CAUTI in males were 1.9 
times (OR=1.995; 95%CI: 0.748-5.318), higher than females. Moreover, as the duration of 
catheterization increased the risk of developing CAUTI increased: patients catheterized for 1 
week were 2.1 times (OR=2.100; 95%CI; 0.666-6.625) and for 2 weeks were 4.5 times 
(OR=4.500; 95%CI; 0.601-33.708) more likely to develop CAUTI, respectively as compared 
to those patients catheterized for three days. 
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In the case of non-catheterized patients sex was significantly associated with the prevalence 
of UTI. The prevalence of UTI in noncatheterized female patients (25%) was higher than in 
male patients (8.1%). The probabilities of being a female in non catheterized patients were 4 
times higher to develop UTI as compared to males. [AOR=3.77, 95% CI= (1.30-10.1.97), 
p=0.015]. The current study also showed statistically significant association between UTI 
and that of underlying disease among non-catheterized patients. Moreover, patients that have 
history of underlying disease were 3 times at higher risk to develop UTI (AOR=3.262; 95% 
CI= (1.147-9.273); P=0.027) (Table 5). 
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Table 5: Association of risk factors with UTI among catheterized and non-catheterized patients at University of Gondar 
Referral Hospital,February to May/2017. 
 Catheterized patients Non-catheterized patients 
Variables Significant Bacteriuria Significant Bacteriuria 
 Pos  
n (%) 
Neg  
n (%) 
COR AOR (95%CI) P-value Pos n(%) Neg n(%) COR AOR (95%CI) P-
value 
Sex     Male 
         Female 
19 (48.7) 20 (51.3) 1 1  5 (8.1) 57 (91.9) 1 1  
10 (32.3) 21 (67.7) 1.995* 2.213 (0.755-6.481) 0.147 19 (25) 57 (75) 3.800* 3.770(1.29510.971) 0.015* 
Age (Years)           
<15  1 (50) 1 (50) 1 1  1 (33.3) 2 (67.7) 1 1  
15-24 2 (67.7) 1 (33.3) 2.000   3 (11.1) 24 (88.9) 0.250   
25-34 4 (36.4) 7 (63.6) 0.571   6 (12) 44 (88) 0.273   
35-45 4 (36.4) 7 (63.6) 0.571   5 (20) 20 (80) 0.500   
>45 18 (41.9) 25 (58.1) 0.720   9 (27.3) 24 (72.7) 0.750   
Catheter 
duration  
          
3 days 6 (25) 18 (75) 1 1        
1 week  14 (41.2) 20 (58.8) 2.100* 2.100 (0.666-6.625) 0.206      
2  weeks  3 (60) 2 (40) 4.500* 4.500 (0.601-33.708) 0.143      
>2 weeks 6 (85.7) 1 (14.3) 18.00* 18.00(1.787-81.311) 0.014*      
 Previous 
catheterizatio
n 
          
No 28 (42.4) 38 (57.6) 1 1  23 (17) 112 (83) 1 1  
Yes 1 (25) 3 (75) 0.452   1(33.3) 2 (66.7) 2.435   
Previous  UTI           
No 28 (41.2) 40 (58.8) 1 1  17 (16.2) 88 (83.8) 1 1  
Yes 1 (50) 1 (50) 1.429   7 (21.2) 25 (78.8) 1.394   
Underlying 
disease 
          
No 23 (42.6) 31 (57.4) 1 1  16 (13.9)  99 (86.1) 1 1  
Yes 6 (37.5) 10 (62.5) 0.809   8 (34.8) 15 (65.2) 3.300* 3.262 (1.147-   
9.273) 
0.027* 
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4.6. Antimicrobial susceptibility patterns of bacterial isolates  
The antimicrobial susceptibility patterns of the Gram negative and Gram positive bacterial 
isolates are presented in (Table 6 and 7) respectively. All Gram-negative isolates from both 
groups of patients (non-catheterized and catheterized) showed a high level (100 %) of 
resistance to ampicillin and augmentin. E.coli isolate showed high level of resistance to 
augmentin and ampicillin (n=12; 100%) and nalidixic acid (n=5; 41.66 %%). On the other 
hand high level of sensitivity were found to nitrofurantoin, gentamicin, amikacin and 
ceftriaxone each 11 (91.7%) and cefepime 10(83.4%). K.pneumoniae also showed high level 
of resistance to augmentin and ampicillin (n=9; 100%) but 88.9% (n=8) isolates were 
sensitive to ciprofloxacin, norfloxacin and cefepime. Proteus mirabilis, Enterobacter species 
and Citrobacter species which were isolated only catheterized patients showed high level of 
resistance to many antimicrobial disks. Proteus mirabilis showed high level of resistance to 
10 antimicrobials (100%) but it was susceptible for amikacin. Enterobacter spp and 
Citrobacter spp were also 100% resistant to ceftriaxone, amikacin, augmentin, ampicillin and 
cefepime. However, Enterobacter spp were sensitive 2 (100%) to nitrofurantoin and 
amikacin. On the other all pseudomonas aeruginosa which was also isolated only 
catheterized patients showed 2(100%) sensitivity for all antimicrobials tested (Table 6). 
The antimicrobial susceptibility pattern of the Gram positive bacterial isolate showed that 
coagulase negative Staphylococcus species were highly resistant to cotrimoxazole  (n=9; 
82%), ciprofloxacin and cefoxitine each (n=6; 55%), and tetracycline (n=5; 45%). However, 
coagulase negative Staphylococcus species isolates were sensitive to nitrofurantoin (n=11; 
100%) and norfloxacin (n=8; 73%). The majority of the S.aureus were resistant to 
Cotrimoxazole (n=8; 89 %), penicillin and tetracycline each (n=7; 78%) and cefoxitine (n=5; 
57%). Nevertheless, most isolates of S.aureus were sensitive to nitrofurantoin (n=9; 100%), 
ciprofloxacin (n=7; 78%), and norfloxacin (n=6; 67%). Since 5(57%) of S.aureus isolates 
were resistance to cefoxitine, methicillin resistance S.aureus was detected in 55.6% cases. 
On the other hand, all Enterococcus species were 4 (100%) resistant to tetracycline, 
erythromycin and ciprofloxacin. Among all isolates of Enterococcus species, 50% were 
vancomycine resistant. 
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4.6.1. Comparison of antimicrobial resistance patterns of isolates from catheterized and 
noncatheterized UTI patients 
E.coli pathogens isolated from catheterized patients showed high level of resistance to 
ampicillin and augmentin (100%) and 50% of the isolates also showed resistance to 
ciprofloxacin, norfloxacin, nalidixic acid, cefepime and cefexime whereas, 100% of E.coli 
isolates from non-catheterized patients were also resistant to augmentin and ampicillin. In 
addition, relatively lower resistance to ciprofloxacin, norfloxacin, nalidixic acid, cefepime 
and cefexime (20%, 20%, 40%, 20, 10%, respectively) was observed among non-catheterized 
patients (Table 6). 
Coagulase negative Staphylococci isolated from catheterized patients showed high level of 
resistant to cefoxitine and ciprofloxacin (100% and 60%, respectively). However, it showed 
low level of resistance to cefoxitine (17%) and ciprofloxacin (50%) for noncatheterized 
patients. S.aureus isolate from catheterized patients also showed high level of resistance to 
penicillin, cotrimoxazole, tetracycline, gentamycin and cefoxitine (100%, 100%, 80%, 67% 
respectively) whereas, isolates from noncatheterized patients showed low level of resistance 
for cotrimoxazole, tetracycline and  penicillin (67%, 67%, 33%, respectively). 
The overall prevalence of multidrug resistance pattern was 41 (73.2%) while only 3(5.4%) 
isolates were susceptible to all antimicrobial disks. Of the 9 (16.1%) K. pneumoniae isolates, 
8(88.9%) isolates showed multiple drug resistance and only one was found to be resistant to 
one antibiotic. On the other hand, all isolates of Enterococcus spps, Citrobacter spps, 
Enterobacter spps and Proteus mirabilis showed multidrug resistance to three or more 
antibiotic classes (Table 8).  
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Table 6: Antimicrobial sensitivity pattern of Gram negative bacteria isolated from catheterized and non-catheterized UTI 
patients at University of Gondar Referral Hospital, February to May/2017. 
 
Catheterized case 
DSP                                   Antimicrobial agent number (%) 
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E.coli (n=2) S 1(50) 1(100) 1(50) 2(100) 1(50) 0(0) 0(0)     1(50)         1(50) 2(100) 2(100) - - 
 R 1(50) 0(0) 1(50) 0(0) 1(50) 2(100) 2(100) 1(50) 1(50) 0 0(0) - - 
K.pneumoniae (n=7) S 6(86) 4(57) 6(86) 5(71) 6(86) 0(0) 0(0) 5(71) 6(86) 4(57) 5(71) - - 
R 1(14) 3(43) 1(14) 2(29) 1(14) 7(100) 7(100) 2(29) 1(14) 3(43) 2(29) - - 
Enterobacter 
spp(n=3) 
S 1(33) 0(0) 1(33) 2(67) 0(0) 0(0) 0(0) 0(0) 0(0) 2(67) 1(33) - - 
R 2(67) 3(100) 2(67) 1(33) 3(100) 3(100) 3(100) 3(100) 3(100) 1(33) 2(67) - - 
Citrobacter spp(n=2 S 0(0) 0(0) 0(0) 2(100) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 2(100) - - 
R 2(100) 2(100) 2(100) 0(0) 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) 0(0) - - 
P.aeruginosa(n=2) S 2(100) - 2(100) - - - - - 2(100) 2(100) 2(100) 2(100) 2(100) 
R 0(0) - 0(0) - - - - - 0(0) 0(0) 0(0) 0(0) 0(0) 
P.mirabilis 
(n=1) 
S 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 1(100) - - 
R 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 0(0) - - 
Serratia spp(n=1) S 1(100) 1(100) 1(100) 1(100) 1(100) 0(0) 0(0) 1(100) 1(100) 1(100) 1(100) - - 
R 0(0) 0(0) 0 0(0) 0(0) 1(100) 1(100) 0(0) 0(0) 0(0) 0(0) - - 
Total(n=18) S 11(61) 6(38) 11(61) 12(75) 8(50) 0(0) 0(0) 7(44) 10(63) 11(69) 14(88) 2(100) 2(100) 
 R 7(39) 10(62) 7(39) 4(25) 8(50) 16(100) 16(100) 9(56) 6(37) 5(31) 2(12) 0(0) 0(0) 
Non-catheterized                
E.coli 
(n=10) 
S 8(80) 9(90) 8(80) 9(90) 6(60) 0(0) 0(0) 8(80) 9(90) 9(90) 9(90) - - 
R 2(20) 1(10) 2(20) 1(10) 4(40) 10(100) 10(100) 2(20) 1(10) 1(10) 1(10) - - 
K.pneumoniae 
(n=2) 
S 2(100) 2(100) 2(100) 1(50) 1(50) 0(0) 0(0) 2(100) 2(100) 1(50) 2(100) - - 
R 0(0) 0(0) 0(0) 1(50) 1(50) 2(100) 2(100) 0(0) 0(0) 1(50) 0(0) - - 
Serratia spp 
(n=2) 
S 1(50) 2(100) 1(50) 2(100) 1(50) 0(0) 0(0) 1(50) 2(100) 1(50) 2(100) - - 
R 1(50) 0(0) 1(50) 0(0) 1(50) 2(100) 2(100) 1(50) 0(0) 1(50) 0(0) - - 
Total(n=14) S 11(79) 13(93) 11(79) 12(86) 8(51) 0(0) 0(0) 11(79) 13(93) 11(79) 13(93) - - 
R 3(21) 1(7) 3(21) 2(14) 6(49) 14(100) 14(100) 3(21) 1(7) 3(21) 1(7)   
DST-Drug susceptibility pattern,CPR-ciprofloxacine,CTR-Ceftrixone,NOR-Norfloxacine,NIT-Nitrofurantoin,NAL-Nalidixic acid,AUG-
Augumentine,AMP-Ampicilline,CXM-Cefexime,CFP-Cefepime,CN-Gentamicine,AKN-Amikacine,CAZ-Ceftazidime,PRL-Pipracilline
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Table 7: Antimicrobial sensitivity pattern of Gram positive bacteria isolated from catheterized and non-catheterized UTI 
patients at University of Gondar Referral Hospital, February to May/2017. 
Catheterized case DSP                                   Antimicrobial agent number (%) 
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S.aureus 
(n=6) 
S 0(0) 2(33) 1(20) 2(33) - - 4(67) 0(0) 3(50) 6(100) 
R 6(100) 4(67) 5(80) 4(67) - - 2(33) 6(100) 3(50) 0(0) 
CONS (n=5) S 3(60) 1(20) 3(60) 0(0) - - 2(40) 1(20) 4(80) 5(100) 
R 2(40) 4(80) 2(40) 5(100) - - 3(60) 4(80) 1(20) 0(0) 
Enterococcus spp 
(n=2) 
S 1(50) - 0(0) - 0(0) 1(50) 0(0) - - - 
R 1(50) - 2(100 - 2(100) 1(50) 2(100) - - - 
Total (13) S 4(31) 3(27) 4(31) 2(18) 0(0) 1(50) 6(46) 1(9) 7(64) 11(100) 
R 9(69) 8(73) 9(69) 9(82) 2(100) 1(50) 7(54) 10(91) 4(36) 0(0) 
Non catheterized            
 S.aureus (n=3) S 2(67) 3(100) 1(33) 2(67) - - 3(100) 1(33) 3(100) 3(100) 
R 1(33) 0(0) 2(67) 1(33) - - 0(0) 2(67) 0(0) 0(0) 
CONS (n=6) S 4(67) 5(83) 3(50) 5(83) - - 3(50) 1(17) 4(67) 6(100) 
R 2(33) 1(17) 3(50) 1(17) - - 3(50) 5(83) 2(33) 0(0) 
Entrococcus spp 
(n=2) 
S 0(0) - 0(0) - 0(0) 1(50) 0 - - - 
R 2(100) - 2(100) - 2(100) 1(50) 2 - - - 
Total (n=11) S 6(55) 8(89) 4(36) 7(78) 0(0) 1(50) 6(56) 2(22) 7(78) 9(100) 
R 5(45) 1(11) 7(64) 2(22) 2(100) 1(50) 5(44) 7(78) 2(22) 0(0) 
DST-Drug susceptibility pattern PEN-Pencillin,CN-Gentamicin,TET-tetracycline,CXT-Cefoxitine,ERY-Erythromicine,VAN-
Vancomicine,CPR- Ciprofloxacine,COT-Cotrimoxazole,NOR-Norfloxacine,NIT-Nitrofurantoin,CONS-Coagulase negative 
staphylococcus specie
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Table 8: Multi-drug resistant patterns in bacterial pathogens isolated from urine 
cultures among catheterized and non-catheterized patients attending the University of 
Gondar Referral Hospital, February to May/2017. 
                                                                          Anti-biogram patterns (%) 
Bacterial isolates No (%) R0 R1 R2  R3   R4     ≥ R5 MDR 
E.coli 12(21.4) 0 0 5(41.7) 4(33.3) 0 3(25.0) 7(58.3) 
Klebsiella pneumoniae 9(16.0) 0 0 1(11.1) 4(44.4) 2(22.2) 2(22.2) 8(88.9) 
Serratia spp 3(5.4) 0 0 1(33.3) 0 0 2(66.6) 2(66.7) 
Citrobacter spp 2(3.6) 0 0 0 0 0 2(100) 2(100) 
Enterobacter spp 3(5.4) 0 0 0 0 0 3(100) 3(100) 
P.aeruginosa 2(3.6) 2(100) 0 0 0 0 0 0(0) 
Proteus mirabilis 1(1.8) 0 0 0 0 0 1(100) 1(100) 
CoNS 11(19.6) 1(9.1) 2(18.2 0 4(36.4) 0 4(36.4) 8(72.7) 
S.aureus 9(16.0) 0 0 3(33.3) 2(22.2) 2(22.2) 2(22.2) 6(66.7) 
Entrococcus spp 4(7.1) 0 0 0 2(50) 2(50) 0 4(100) 
Total No (%) 56(100) 3(5.4) 2(3.6) 10(17.9) 13(23.2) 9(16.0) 19(33.9) 41(73.2) 
Keys: R0= No antibiotic Resistance R1=Resistant to one antibiotic class, R2=Resistant to two antibiotic class, 
R3= resistant to three antibiotic class, R4=Resistant to four antibiotic class, R5=Resistant to five and more than 
five antibiotic class, CoNS=Coagulase negative Staphylococci 
 
 
 
 
 
 
 
29 
 
5. DISCUSSION 
Urinary tract infections (UTI) are likely to be more common in lower income countries than 
in the developed world (54). In the developed world with ready access to health care and 
antibiotic therapy, UTI tends to be cured very quickly Urinary tract infection attributed to the 
use of an indwelling urinary catheter is one of the most common infections acquired by 
patients in health care facilities (55). 
In the present study the overall prevalence of UTI in both catheterized and non-catheterized 
patients was 25.5%. This finding was in agreement with the previous studies conducted in 
Addis Ababa 23% (45), Dessie 27.35% (46) and Bahirdar 30.2% (49). However, there was a 
report from Gondar (the same study area) with higher prevalence of UTI (52.8%) (56), while 
it was higher than reports from Jimma 9.2% (57) and Iran 8.06% (39). The differences in the 
prevalence of uropathogens might have been due to sample size variation, study design or the 
studies might have been based on retrospective survey and different environmental 
conditions and host factors, practices such as healthcare and education programmers, 
socioeconomic standards and hygiene practices in each geographical area. 
Data of the present study also showed that the prevalence of UTI was higher among 
catheterized patients (41.4%) than non-catheterized patients (17.4%). These result also 
showed the presence of a statistically significant difference in the frequency of detection of 
UTI from non-catheterized and catheterized patients (17.4% versus 41.4%, p<0.05). This 
finding was concordant with the studies conducted in Jimma (43.3% vs22.2%) (45), and in 
Mekelle (39.5% vs12.5%) (47) for catheterized and noncatheterized patients, respectively. 
However, report from Saudi Arabia showed that the prevalence of community acquired and 
hospital acquired urinary tract infection was reported 55.3% and 44.7%, respectively (37). 
Different reports showed that catheter subverts several host defences and provides new 
binding sites for bacterial adhesins and its presence encourages the organism’s persistent 
residence in the urinary tract (58). The risk factors that was significantly associated with that 
of CAUTI in the present study was the duration of the application of catheter (P=0.014). This 
data showed that patients catheterized for more than 2 weeks time had a UTI rate of 85.7%. 
Previous report from Nigeria documented that patients catheterized for more than 2 weeks 
had a UTI rate of 100% (59). 
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 Catheter-associated urinary tract infection is the most common nosocomial infection in 
hospitals and nursing homes, comprising >40% of all institutionally acquired infections (10). 
Although sex was statistically insignificant, catheterized males had higher odds of UTI as 
compared to catheterized females. This might have been due to males have narrow urethra 
which may be damaged during catheterization as compared to females.  
Among risk factors studied for non-catheterized UTI, sex was found to be important factor (P = 
0.015). Females had a higher prevalence of UTI (25%) as compare to males (8.1%) in this study. 
There are also reports that documented higher prevalence of UTI among females compared with 
males in Saudi Arabia (78.7%vs21.3%) (37), Iran (88.7%vs11.3%) (39) and India 
(64.2%vs35.7%) (41). Women are more likely to develop UTIs than men. This is because, in 
women, the opening of the urethra is in close proximity to the anus and vagina, organisms can 
readily move from these openings to the urethra. The female urethra is also much shorter and 
wider than the male urethra, making it easier for bacteria to reach the bladder (14). Data of the 
present study showed no statistically significant association between age and UTI. However, 
UTIs are common in older adults. It is second only to respiratory infections in hospitalized 
patients and community-dwelling adults over the age of 65 years (60). 
Another risk factor significantly associated with UTI in the present study was the presence of 
underlying disease (p=0.027). The odds of UTI in noncatheterized patients were higher in 
patients with underlying disease (35%) than who had no underlying disease (13%). This was 
consistent with previous studies of Debre tabor hospital, Ethiopia (10.9% and 4.7%) for 
diabetics and non diabetic patients respectively (61). The pathogenesis of UTI in patient with 
diabetes has been studied and the increased susceptibility is attributed to several impairments 
of host defence mechanisms such as leukocyte adherence, chemotaxis, and phagocytosis that 
can be impaired in diabetic patients (62). In addition, various impairments in the immune 
system, poor metabolic control, and incomplete bladder emptying due to autonomic 
neuropathy may all contribute to the enhanced risk of urinary tract infections in these patients 
(63).    
At the time of diagnosis, catheterized patients with symptoms of dysuria and flank pain and 
non-catheterized patients with dysuria, suprapubic pain and tenderness were more likely to 
have culture confirmed UTI. This finding has significant value for physicians who are 
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working in resource limited countries where there is lack of microbiological culture in all 
health facilities.  The term dysuria is used to describe painful urination, which often signifies 
an infection of the lower urinary tract. The discomfort is usually described by the patient as 
burning, stinging or itching. Pain occurring at the beginning of or during urination suggests a 
urethral site of disease, whereas pain after voiding implies pathology within the bladder or 
prostate area (64). 
The present study showed that the etiologic pathogens of UTIs were mainly belongs to gram-
negative bacteria 32 (57%) than Gram positive bacteria 24 (43%). This was in line with the 
previous studies conducted elsewhere (35, 43, 45). In this study, among catheterized patients, 
Klebsiella pneumonia was found to be the most frequently isolated pathogens which account 
7(22.6%). This result was consistent with reports from Nigeria 26.6% (59). In contrast to 
reports from Jimma, Staphylococcus aureus was found to be the second most frequent 
pathogen accounts 19.4%. On the other hand, among the noncatheterized patients, E.coli was 
the most frequently isolated bacteria which was (40%) and Coagulase negative 
staphylococcus species was the second most frequent pathogen accounts (24%). This result 
also agrees with previous report from Jimma (45). 
In this study, isolates of Pseudomonas aeruginosa, Proteus mirabilis, Citrobacter spp. and 
Entrococcus spp. were found exclusively among catheterized patients. There are reports that 
showed UTI caused by many of the aforementioned bacteria could possibly be nosocomial 
origin. Particularly, UTI caused by Pseudomonas species and Proteus species are associated 
with hospital acquired infections often following catheterization (31, 52). 
Gram-negative isolates from both groups of patients (non-catheterized vs. catheterized) 
showed a high level (100%) of resistance to ampicillin and augmentin. This result showed 
high resistance rate than the previous studies in the same area 95.2% (56) and Bahirdar 80% 
(50). This change of resistance pattern might be due to self-medication and indiscriminate 
use of antibiotics in the study area. On the other hand high level of sensitivity were detected 
to antibiotics such as amikacin, ceftriaxone, ciprofloxacin, norfloxacin, nitrofurantoin, 
nalidixic acid, gentamicin, cefepime, cefexime and a comparable rate of sensitivity has been 
reported for these drugs in the previous studies in India (41) and Debretabor (61). Low 
resistance was observed for these drugs because they are not easily accessible and relatively 
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expensive in price compared to others. Thus, these drugs could be considered as alternative 
options in the empirical treatment of UTIs. Similarly, in this present study, a higher 
proportion of isolates of gram positive bacteria were in average resistant to cotrimoxazole 
(84.5%), tetracycline (66.5%), penicillin (58.3%), and ciprofloxacin (49%). This result was 
also consistent with report from Debretabor (61). In this study, methicillin resistant S.aureus 
was detected in 55.6% of cases. It was lower than reports from India (66.6%) (41). 
Bacterial pathogens isolated from catheterized patients showed high resistance rate than 
noncatheterized ones. The E.coli isolates from catheterized patients exhibited resistance to 
ciprofloxacin, norfloxacin, nalidixic acid, cefepime and cefexime(50%) for each, whereas 
E.coli from noncatheterized patients were less resistant to the above mentioned antibiotic 
disks.  
In addition to these, CoNS isolated from catheterized patients showed more resistant to 
cefoxitine, gentamycin and ciprofloxacin than noncatheterized patient isolate. Whereas, 
S.aureus isolate from catheterized patients also showed resistance to penicillin, 
cotrimoxazole, tetracycline, gentamycin and cefoxitine than noncatheterized patients. 
Entrococcus species from catheterized patients also exhibited (100%) resistance to 
ciprofloxacin than noncatheterized ones. This result is consistent with previous report from 
Jimma (45) and Bahirdar (50).This change of resistance between catheterized and 
noncatheterized bacterial isolate might be because of all isolates from catheterized patients 
were of nosocomial origin, the wide use of antimicrobial agents in the hospital setting may 
contribute for the particular resistance pattern of catheter urine isolates or bacterial isolates in 
catheterized patients might be going to biofilm formation covered by strong polymicrobial 
structure which leads the bacteria resistant to many antimicrobials.  
In this study multidrug resistance to three or more antimicrobial classes was observed in 
73.2% of the isolates. This was consistent with the previous report from Bangladish 70.67% 
(65) and lower than the previous report from Bahirdar 93.1% (50) and Gondar 86.5% (56). 
The lower multidrug resistance rate of isolates in this study could be due to rational use of 
antimicrobial agents or the present study used a recent guideline about the definition of MDR 
allowed to decrease from the previous reports.  
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6. LIMITATIONS OF THE STUDY 
This study had limitations including being hospital based study where asymptomatic cases of 
UTI might have been missed further limiting its generalizability to the whole population. It 
also involved a small sample size especially for antimicrobial susceptibility testing which 
limits the recommendations for revising treatment guidelines. Moreover, due to lack of 
facility and budget isolation of other etiologic agents including anaerobic bacteria, bacteria 
unable to grow on culture, parasites, fungi and virus were not done.   
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7. CONCLUSION  
One fourth of clinically suspected UTI patients had culture confirmed UTI. Catheterized 
patients for more than two weeks and non-catheterized females and patients with chronic 
diseases had higher isolation rates of bacterial pathogens as compared to their counter parts. 
The predominant bacterial isolates were E.coli followed by Coagulase negative 
staphylococcus species, K. pneumoniae and S. aureus. Isolation of E.coli was significantly 
associated with non catheterized patients. Amikacin, nitrofurantoin, norfloxacin, 
ciprofloxacin and ceftriaxone were the drug of choice for gram negative isolates whereas 
nitrofurantoin, norfloxacin and gentamicin were for most gram positive bacteria. 
Alarmingly high rate of MDR to commonly used antimicrobials from UTIs were reported. 
Particularly, increasing resistance in pathogens isolated from catheterized patients is 
frustrating.  
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8. RECOMMENDATIONS 
 
Based on this study the following recommendations are made: 
 
➢ Physicians working in a hospital should follow strict aseptic technique during 
indwelling catheter insertion and minimize the duration and unnecessary use to 
reduce the risk of CAUTIs.  
➢  Catheterized patients for more than 2 weeks should be screened for UTI using culture 
and treated based on antibiotic sensitivity test rather than empirical treatment.   
➢ Medical Microbiologists in the hospital integrated with the academic staff should 
conduct continuous surveillance to check the pattern of common bacterial isolate and 
antibiotic resistance including MDR.  
➢ Researchers should conduct a robust study with large number in multisite inform 
policy makers and concerned bodies to change a guideline.   
➢ The hospital administration has to strengthen the existing antimicrobial stewardship 
committee to reduce emergence of antimicrobial resistance.  
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                                      ANNEXES 
Annex I: Information sheet and consent form 
Study Title፡ Assessment of bacterial pathogens, antimicrobial susceptibility pattern and 
associated risk factors among catheterized UTI suspected patients compared with non 
catheterized ones at University of Gondar referral hospital, Northwest Ethiopia. 
Name of the Sponsor:  Amhara Regional Health Bureau. 
Name of the Organization:   School of Biomedical and Laboratory Sciences, Gondar 
College of Medicine and Health Sciences, University of Gondar. 
1. Purpose of the Research Project: The aim of this study is to assess the Bacterial 
Pathogens, their antimicrobial Susceptibility Pattern and associated risk factors among 
catheterized UTI suspected patients compared with non-catheterized ones attending 
University of Gondar referral hospital, Gondar, North West Ethiopia. In line with this the 
findings will also provide baseline information for health sector administrators, concerned 
bodies and the patients themselves in planning and managing of UTIs that further reduce the 
morbidity and mortality associated with the disease. 
2. Procedure: In order to perform the above mentioned study at University of Gondar 
referral hospital, you are invited to take part in this project. If you are willing to participate, 
you need to understand the purpose of the study and give your consent .The required clinical 
sample will be collected by nurses and who are currently working inpatient and outpatient 
department of the hospital. Then, you will be requested to give your consent to the sample 
collector. Socio-demographic, associated factors and clinical information will be collected 
from the study participants using pre tested structured questionnaires via interview technique; 
since you fulfil the criteria you are kindly requested to give the  required urine sample and 
genuine answers to the prepared questionnaire. 
3. Risk associated with the study: You will not be at any physical or psychological risk and 
no damage resulting from the research procedures. 
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4. Benefits of the study:  Based on the diagnosis result you will be treated accordingly. 
Moreover, this study will have a great value on preventive measures in hospitals and in the 
community. The results of this study have importance to treat the patients and to use as a 
baseline for effective treatment in the absences of laboratory investigation 
5. Compensation for participation:  You will not receive any payment for your 
participation in this research study. 
6. Confidentiality of your information- All information gathered from the study participant 
will remain confidential. Your participation in this study is strictly anonymous. Personal 
information will be treated confidentially and under no circumstances it will not be 
transmitted to any person or organization. The results of this study will be evaluated and 
summarized, and a feedback of the results to the study participants will be given by principal 
investigator. 
7.  Right to Refusal or Withdraw:  Your participation in the study is absolutely voluntary; 
you have full right to refuse from participating in this research. You can refuse to give   
sample and not to respond any or all the questionnaires and this will not affect you on using 
any kind of services from the hospital. 
8. Person to Contacts:  This research project will be reviewed and approved by Ethical 
clearance committee of School of Biomedical and laboratory Sciences, College of Medicine 
and Health Sciences, University of Gondar. If you want to know more information, you can 
contact the following individuals and you may ask at any time as you want:- 
                                  1-School of Biomedical and Laboratory Sciences, UOG 
                           P.Box-196, Gondar, Ethiopia 
                                  2. Mr.Wudu Tafere, principal investigator 
                                      Mobile: +251918072587/ e-mail:  taferewudu@gmail.com 
                                   3. Dr Baye Gelaw, (advisor), University of Gondar  
                                       Mobile:  0918 703723   /e-mail: tedybayegelaw@gmail.com 
                                   4. Mr.Teklay G.cherkos, (advisor), University of Gondar 
                                        Mobile: 0922795314 /e-mail estiftg17@gmail.com  
44 
 
Consent form 
Serial No------------------Name of health institution----------------------Card No-------------------        
Date-------------- 
I the undersigned study participant with urinary tract infection have been well informed 
about the objective of the study entitled “Assessment of Bacterial Pathogens and their 
Antimicrobial Susceptibility Pattern among UTI patients with history of Catheter compared 
with non-Catheterized ones attending Gondar referral hospital, North West Ethiopia, 
February to May 2017. 
I am also informed that all the information obtained at any course of the study is to be kept 
confidential. Moreover, I have also been well informed of my right to keep hold of, decline 
to cooperate and drop out of the study if I want and none of my actions will have any bearing 
at all on my overall health care and hospital access. 
I agreed voluntarily to provide the requested samples from me as well as my child. 
 
Name and signature of study participant   _________________ Date_____________  
Name and signature of investigator            ________________   Date_____________ 
 
 
Assent form for child 
I have read and/or listened to the description of the study and I understand what the 
procedures are and what will happen to me in the study. I have received permission from my 
parent(s)/guardian(s) to participate in the study and I agree to participate in it. I know that I 
can quit the study any time. 
 ________________________________     _____________________ 
   Signature of Child /guardians                                         Date 
 ________________________________     _____________________ 
  Signature of Investigator                                                 Date 
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Annex II: Amharic Version Study Participant Information and Consent Form 
 የመረጃና የስምምነት ዉል ቅጽ  
 የጥናቱ ርእስ -የሸንት ቧንቧ ህመምን የሚያመጡ የባክተሪያ ዝርያዎችን ካቲተር በሚጠቀሙና በማይጠቀሙ በሸተኞቸ 
ላይ መለየትና ለጸረ-ባክቴሪያ መድሃኒት ያላቸውን ሁኔታ ለማወቅ በጎንደር ሪፈራል ሆስፒታል በሚታከሙ ሕመምተኞች 
ሸንት ውስጥ መኖራቸውን መለየት  
 የጥናቱ ደጋፊ - የአማራ ብሔራዊ ክልላዊ መንግስት ጤና ቢሮ፡፡ 
 የድርጅቱ    ስም  ጎንደር  ዩኒቨርሲቲ ህክምና ና ጤና ሳይንስ ኮሌጅ የላቦራቶሪ እና ባዮሜዲካል ትምህርት ቤት  
1. የጥናቱ ዓላማ- የዚህ ጥናት አላማ የሸንት ቧንቧ ህመምን የሚያመጡ የባክተሪያ ዝርያዎችን ካቲተር 
በሚጠቀሙና በማይጠቀሙ በሸተኞቸ ላይ መለየትና ለጸረ-ባክቴሪያ መድሃኒት ያላቸውን ሁኔታ ለማወቅ  
በጎንደር ሪፈራል ሆስፒታል በሚታከሙ ህመምተኞች ሸንት ውስጥ መኖራቸውን መለየትና ማሳወቅ 
ነው፡፡አያይዞም ከጥናቱ የሚገኘው ውጤት ለጤና ተቋም አስተዳዳሪዎች ለሚመለከታቸው አካላት እና 
ለሕሙማን ለራሳቸው በዚህ ጀርም የሚከሰተውን ሕመምና ሞት ለመከላከል መሠረታዊ መረጃዎችን 
ይሰጣል፡፡ 
2.  የአሰራር ሂድት- ይህን ጥናት በጎንደር ሪፈራል ሆስፒታል ለመስራት የጥናቱ  ተሳታፊ እንዲሆኑ ተጋበዘዋል፡፡ 
ለመሳተፍ  ፍቃደኛ  ከሆኑ  የጥናቱን ዓላማ መረዳትና ፍቃደኝነትዎን መግለፅ ይጠበቃል፡፡ለዚህ ጥናት 
የሚያስፈልገው የቁስል ናሙና  የሚሰበሰበው በጥናቱ  ወቅት በተመላላሽና ተኝቶ ታካሚ  ክፍል ዉስጥ 
በሚሰሩ ነርሶች ይሆናል፡፡እንዲሁም በተጨማሪ ማህበራዊ ነክ  አጋላጭ ሁኔታዎች እና የጤንነት  ሁኔታን 
የሚያሳዩ ጥያቀዎች  ከያንዳንዱ የጥናቱ ተሳታፊዎች  በመጠይቁ መሰረት ይሰበሰባል፡፡እርስዎም  መስፈርቱን  
እስካሟሉ ድረስ  የሚያስፈልገዉን ናሙና ለመስጠት  እና ለተዘጋጀው ጥያቄ ትክክለኛ ምላሽ እንዲሰጡ 
በትህትና  ይጠየቃሉ፡፡ 
3. ከጥናቱ ጋር ተያይዞ የሚመጣ ጉዳት - በዚህ ጥናት ዝርዝር ኣሰራር ሂደት ውስጥ አካላዊ ወይም አእምሮአዊ 
ጉዳት አይኖርም፡፡  
4. ጥቅሞች - በምርመራ ውጤትዎ መሠረት ሕክምና ያገኛሉ በተጨማሪም ይህ ጥናት የመከላለል ስራ 
በሆሰፒታል እና በህብረተሰቡ ዘንድ እንዲኖር ያግዛል፡፡ እንደዚሁም ደግሞ የላቦራቶሪ አገልግሎት በሌለበት 
ጤና ተቋም ትክክለኛ መድሃኒት ለመስጠት እንደ አመላካች ሆኖ ያገለግላል፡፡ 
5. ለተሳትፎ የሚሰጥ ማካካሻ- ምንም አይነት የካሳ ክፍያ የለዉም 
6. የጥናቱ መረጃ ሚስጥራዊነት  ሁሉም ከተሳታፊዎች የሚሰበሰቡ መረጃዎች በሚስጢር የሚያዙ እና የሚጠበቁ 
ይሆናሉ፡፡ በማንኛውም ምክንያት ተሳታፊዎች እነማን መሆናቸውን የሚያሳይ በመጠይቁ ይሁን በሌላ ነገር 
አይኖርም፡፡ የተሰበሰቡ መረጃዎች ለሶስተኛ ወገን ተላልፎ አይሰጥም፡፡ በተጨማሪም ውጤቱ የሚለካዉ ይሁን 
ተሰብስቦ የሚያዘው በዋና አጥኚ ነው፡፡ 
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7. የመዉጣት (የማቋረጥ) መብት -  በዚሀ ጥናት ላይ መሳተፍዎ በሙሉ ፍቃደኝነት ላይ የተመሰረተ ነው 
::ጥናቱን የማቋረጥ ሙሉ መብት አለዎት ፡፡ ናሙናም ሆነ ለመጠይቁ መልስ ያለመስጠት ከሆስፒታሉ 
የሚያገኙትን ማነኛውንም አገልግሎት አይገድብም ፡፡ 
8. የሚያገኙዋቸው ሰዎች- ይህ ጥናት በጎንደር ዪኒቨርሲቲ የስነምግባር ምርምር ኮሚቴና ሕክምናና ጤናሳይነንስ 
ኮሌጅ የላቦራቶሪ ባዮሜዲካል ትምህርት ክፍል ተዕልኮ የሚጸድቅ ይሆናል፡፡ ጥያቄ ካለዎት ተጨማሪ መረጃ 
ከፈለጉ በማንኛዉም ጊዜ ከዚህ በታች የተጠቀሰዉን አድራሻ መጠቀም ይችላሉ፡፡  
         
1.  ባዮ ሜዲካል እና ላቦራቶሪ ሳይንስ፡፡ 
                       ፖ.ሳ ቁ-196, ጎንደር ኢትዮጵያ 
2. አቶ ውዱ ታፈረ፡ ዋና ተመራማሪ:   
                                 ስ.ቁ: +251918072587 ኢ.ሜል taferewudu@gmail.com 
3.  ዶ/ር  ባዬ  ገላው: አማካሪ    ጎንደር  ዩንቨርሲቲ 
                                ስ.ቁ:0918703723--ኢ.ሜል tedybayegelaw@gmail.com           
4. አቶ ተክላይ ገ/ጨርቆስ - አማካሪ ጎንደር  ዩንቨርሲቲ                 
                                ስ.ቁ:-0922795314   ኢ.ሜል estiftg17@gmail.com 
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የስምምነት ውል 
የአዋቂዎች የስምምነት ማረጋገጫ ፊርማ                                                                                      
ተራ ቁጥር---------------የሚታከምበት ጤና ተቋም------------------------የካርድ ቁጥር--------------- 
ቀን-------------------------  
እኔ ከዚህ በታች ስሜ የተጠቀሰዉና የፈረምኩት የጥናቱ ተሳታፊ የሸንት ቧንቧ ህመምን የሚያመጡ የባክተሪያ ዝርያዎችን 
የሽንት ማሸኛ ቱቦ በሚጠቀሙና በማይጠቀሙ  በሸተኞቸ ላይ መለየትና ለጸረ-ባክቴሪያ መድሃኒት ያላቸውን ሁኔታ 
በጎንደር ሪፈራል ሆስፒታል በሚታከሙ  ህመምተኞች ሸንት ውስጥ መኖራቸውን ለመለየት እና  ለማሳወቅ  
የሚደረገውን ጥናት አላማና ጥቅም በሚገባ ተረድቻለሁ፡፡ ጥናቱ ላይ መሳተፍም ሆነ አለመሳተፍ በራሴ ፍቃድ የሚወሰን 
መሆኑም ተገልጾልኛል፡፡ በተጨማሪም ከጥናቱ ባልሳተፍም ሆነ አቋርጨ ብወጣ ከሆስፒታሉ በማገኘዉ የህክምና 
አገልግሎት ምንም አይነት ችግር እንደማይደርስብኝ ተነግሮኛል፡፡ 
በመሆኑም ከእኔም ሆነ ከልጄ ሸንት ናሙና መዉሰድ አስፈላጊ መሆኑን ስለተስማማሁበት ለመስጠት ሙሉ ፈቃደኛ 
መሆኔን በፊርማዬ እገልጻለሁ፡፡ 
 
የተሳታፊ  ፊርማ ________________           ቀን _____________________ 
የተመራማሪ ስምና ፊርማ ______________           ቀን ____________________ 
 
የልጆች የስምምነት ማረጋገጫ ፊርማ 
 
እኔ የጥናቱ ተሳታፊ የጥናቱን ሂደት እና በጥናቱ ጊዜ ስለሚያጋጥሙኝ ነገሮች በሚገባ የተረዳሁ ና በጥናቱ ለመሳተፍ 
ከአሳዳጊዎቼ/ ከቤተሰቦቸ ፍቃድ አግንቻለሁ፡፡ ከጥናቱ በማንኛዉም ደረጃ እራሴን ማግለል እንደምችል ተረድቻለሁ 
እናም በጥናቱ ለመሳተፍ ተስማምቻለሁ፡፡  
የተሳታፊዉ ልጅ /አሳዳጊ  ፊርማ-------------------------------ቀን--------------------- 
የዋና ተመራማሪ ፊርማ-------------------------------ቀን--------------------- 
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Annex III: English Version Questionnaire 
Questionnaire for assessment of sociodemographic, clinical profile and laboratory data of 
UTI Patients at University of Gondar referral Hospital, North West, Ethiopia. 
 
Questionnaire code #  
Card #  
Date of data collection  
Name of health institution   
 
I. Socio demographic information  
101. Age ………………  
102. Sex                      1.Male            2.Female 
103. Residence            1.Urban       2.Rural 
104. Occupation          1. Civil servant    2.Farmer     3.Merchant     4.House wife     
                            5. Self employer      6.  Other specify............ 
105. Educational status   1.Unable to write &read    2.Read &write only     3.primary                        
                                          4. Secondary              5.University/college                                                                        
106. Marital status      1.Married     2.Single    3.Divorced     4.Widowed 
107. Patient setting      1.Outpatient               2.Inpatient 
108. If being inpatient, how many days do you stay?    .............. 
109. Ward: Medical __________ 
               Surgical ___________ 
               Gyn & ObS _________ 
               Pediatrics __________ 
               Others __________ 
II. Associated risk factors: 
201. Catheterized Patients                                                         1.Yes             2.No 
202. If yes, for how long:           3 days         1 week        2 weeks     >2 weeks                                   
203. Reason for catheterization…………………….  
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204. If say no; are you pregnant (for female)                              1. Yes           2. No 
        For both catheterized and non-catheterized UTI patient: 
205.  History of previous catheterization:                                    1.Yes          2.No 
206. If yes, state reason for previous catheterization………….. 
207. Did you have past history of UTI with in 1 year                 1.Yes             2.No 
208. If yes how many times? ………….... 
209. History of previous antibiotic treatment                              1.Yes            2.No 
210. Is there any other underlying disease:                                       1.Yes           2.No 
211. If yes, specify the type of disease………………… 
III. Clinical Profile 
                                                                         YES                                          NO 
301. Fever                                                         ____                                          ____ 
302. Dysuria                                                      ____                                          ____ 
303. Urgency                                                     ____                                          ____ 
304. Frequency                                                 ____                                          ____ 
305. Flank pain                                                  ____                                          ____ 
306. Suprapubic pain                                         ____                                          ____ 
307. Others specify:                                           ____                                          ____ 
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IV. Laboratory Data 
401. Date of urine collection----------------- 
402. Type of specimen: Catheter urine sample…………… 
                                 Mid stream urine sample……….. 
403. Cultures and Identification 
                                  Significant bacteriuria: Yes_____ 
                                                                       No_______ 
                                   Name of the bacteria isolated________________ 
 
404. Antimicrobial susceptibility testing                     S                         I                     R 
1. Amikacin                                                                 -----                     ------              ------ 
2. Ampicillin                                                                -----                     -----               ------ 
3. Amoxicillin-clavulanic acid                                    ------                   ------               ------ 
4. Ceftriaxone                                                              ------                   ------              ------ 
5. Ciprofloxacin                                                            ------                   ------              ------ 
8. Nitrofurantoin                                                           ------                   -------              ------- 
9. Cotrimoxazole                                                          ------                   --------            -------- 
10.Nalidixic acid                                                           -------                  --------            -------- 
11.Cefepime                                                                   ------                    -------             ------- 
12.Cefixime                                                                    ------                     -------             ------- 
13. Penicillin                                                                   -------                    --------           -------- 
14.Erythromicine                                                             -------                    --------            ------- 
15. Tetracycline                                                               -------                    --------            ------- 
16. Vancomycine                                                              -------                   -------               -------                                                 
17.Gentamycine                                                               ------                       -------           ------- 
18.Cefoxitine                                                                    -------                     --------           ------- 
V. Comments____________________________________________________ 
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Annex IV: Amharic Version of Questionnaire 
የአማርኛ መጠይቅ 
የጥናቱ ርእስ፡- የሸንት ቧንቧ ህመምን የሚያመጡ የባክተሪያ ዝርያዎችን ካቲተር በሚጠቀሙና በማይጠቀሙ በሸተኞቸ ላይ መለየትና ለጸረ-
ባክቴሪያ መድሃኒት ያላቸውን ሁኔታ ለማወቅ በጎንደር ሪፈራል ሆስፒታል በሚታከሙ ሕመምተኞች ሸንት ውስጥ መኖራቸውን መለየት 
የኮድ ቁጥር   
የመታከሚያ ካርድ ቁጥር  
ናሙናዉ የተወሰደበተ ቀን  
የጤና ተቋሙ ስም  
 
ሀ. ማህበራዊ ና ኢኮኖማዊ መረጃ 
         101 እድሜ ? -------------------- 
         102 
 
ጾታ 1.ወንድ 
2.ሴት 
           
         103 
የትምህርት ደረጃ 
 
1. ያልተማረ        2.ማንበብ እና መጻፍ 
2.የመጀመሪያ ሳይክል 
3. የሁለተኛ ሳይክል 
4. የከፍተኛ  ትምህርት 
         104 መኖሪያ ቦታ 
 
1.ገጠር 
2. ከተማ 
 
         105 
ስራ 1.የመንግስትሰራተኛ   3.  ነጋዴ 
2.ገበሬ              4.  የቤትእመቤት 
5.የቀን ስራ 
6.ሌላ ከሆነ ይግለጹ-------- 
          106  
 
የታካሚዉ ሁኔታ 
 
1.ተኝቶ ታካሚ (ለስንት ቀን ተኙ......) 
2.ተመላላሽ ታካሚ 
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          107 
 
በሽተኛው የተኛበት/ችበት ክፍል 1.ሜዲካል       3.ማዋለጃ ክፍል  
2.ቀዶጥገና ክፍል   4.ህፃናት ክፍል 
5.ሌላ ክፍል... 
        108 
 
የጋብቻ ሁኔታ 1.ያገባ/ች     2.ያላገባ/ች 
3.የፈታ/ች     4.በግልሙትና የሚኖር/የምትኖር 
 
ለ .ለሽንት ቧንቧ ህመም መባባስ አጋላጭ ሁኔታዎች 
ጥያቄ ቁጥር ጥያቄ መለያ 
201 የሽንት ማሸኛ ቱቦ ተጠቃሚ ነዎት? 1. አዎ               2. አይደለሁም 
202 መልስዎ አዎ ከሆነ ምንያህል ጊዜ ሆነዎት? 1. 3 ቀን       3. 2 ሳምንት 
2. 1 ሳምንት    4. ከ2 ሳምንት      በላይ              
203 የሽንት ማሸኛ ቱቦ እንዲጠቀሙ የተደረገበት ምክንያት? ................... 
204 ነፍሰጡር ነዎት?   1.አዎ           2.አይደለሁም 
 የሽንት ማሸኛ ቱቦ ለሚጠቀሙም ለማይጠቀሙም የሚጠየቅ 
205 ከዚህ በፊት የሽንት ማሸኛ ቱቦ ተጠቅመው ያውቃሉ?  1. አዎ      2. የለም 
206 አዎ ከሆነ በምን ምክንያት? .................... 
207 በ 1 አመት ጊዜ ውሰጥ የሽንት ቧንቧ ህመም አሞዎት 
ያውቅ ነበር? 
 1. አዎ (ስንት ጊዜ.....)       2. የለም 
208 መልስዎ አዎ ከሆነ መድሃኒት ወስደው ነበር? 1. አዎ (ምን አይነት)........ 
2. የለም 
209 ሌላ ስር የሰደደ የቆየ ህመም አለዎት? 1.አዎ (ይገለፅ.......)                2.የለም     
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                ሐ. የሽንት ቧንቧ ህመምን አመላካች ምልክቶች 
ጥያቄ ቁጥር       ምልክቶች  አዎ የለም 
301 የሰውነት ሙቀት መጨመር(ትኩሳት) 
 
 
 
 
 
302 ሽንት በሚሸኑበት ጊዜ የማቃጠል ስሜት   
303  ሽንትን መቆጣጠር አለመቻል   
304 ቶሎ ቶሎ የመሽናት ሁኔታ   
305 የሽንጥ/ወገብ ህመም ስሜት   
306 ከሆድ በታች ያለ የህመም ስሜት   
307 ሌላ ካለ ይገለጽ............   
 
                                           አመሰግናለሁ!!! 
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Annex V: Procedures  
A.  Culture media preparation 
1. Read the label on a bottle of dehydrated agar media.  It specifies the amount of 
dehydrated powder required to make 1 litter (1,000 ml) of medium. Calculate the amount 
needed for 1/2 litter and weigh out this quantity. 
2. Place 500 ml of distilled water in an Erlenmeyer flask. Add the weighed, dehydrated agar 
while stirring with a glass rod to prevent lumping. 
3. Set the flask on a tripod over an asbestos mat.  
4. When the agar mixture is completely dissolved, remove the flask from the flame or hot 
plate, close it with the cotton plug or cap, and it has to be sterilized in the autoclave. 
5. When the flask of sterilized agar is returned to you, allow it to cool to about 50°C (the 
agar should be warm and melted, but not too hot to handle in its flask). Remove the plug 
or cap with the little finger of your right hand and continue to hold it until you are sure it 
won’t have to be returned to the flask. Quickly pour the melted, sterile agar into a series 
of petri dishes. The petri dish tops are lifted with the left hand and the bottoms are filled 
to about one-third capacity with melted agar. 
6.  Replace each petri dish top as the plate is poured. When the plates are cool (agar 
solidified), invert them to prevent condensing moisture from accumulating on the agar 
surfaces. 
7. Place inverted agar plates in the 35°C incubator. They should be incubated for at least 24 
hours to ensure their sterility (free of contaminating bacteria) before we use. 
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B. Collection and processing of urine specimen  
The specimen (mid-stream and catheterized urine) will be collected by an experienced nurse 
and special care should be taken to avoid contaminating the specimen with commensal 
organisms from the vagina and skin. 
1. With sterile wide mouth urine cup collect urine sample from UTI patients.    
2. Label the sample as soon as possible with the patient code number 
3. Inoculate in to CLED, MacConkey and blood agar aseptically 
4. Incubate the plate aerobically at 35-37 
 
for 18-24 hours. 
5. Examine and report the culture; look for colony characteristics and perform biochemical 
test. 
6. Determine drug susceptibility pattern of the isolated organism 
C. Gram stain procedures 
1. Prepare a thin smear of the culture or specimen will be observed. 
2. Allow to air-dry and fix the smear. 
3. Cover the fixed smear with crystal violet for 1 min. 
4. Rinse with clean water and tip off all the water. 
5. Cover the smear with Lugol’s iodine for 1 min. 
6. Wash off the iodine with clean water. 
7. Add acetone-alcohol for 30 sec.  
8. Wash the smear immediately with clean water. 
9. Cover the smear with saffranin for 1-2 minutes. 
10. Rinse with clean water. 
11. Wipe the back of the slide and place in a draining rack for the smear to air-dry. 
12. Examine microscopically, first with the 40x objective and then with the oil immersion 
objective for white cells, bacteria and other structures. 
13. Result interpretation 
- Gram- positive bacteria -------------Dark purple 
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- Gram- negative bacteria ------------Pale to dark red. 
 
D. Biochemical testing procedures 
Identification of Gram positive bacteria: Gram-positive cocci will be identified based on 
their Gram reaction, catalase and coagulase test results. 
Catalase test: This test will be used to differentiate staphylococci (+ve) from streptococci (-
ve) 
Procedure 
1. Pour 2-3 ml of 3% hydrogen peroxide to a test tube 
2. Using a sterile wooden stick take the test organism and immerse into the hydrogen 
peroxide solution 
3. Look for immediate bubbling 
4. Interpretation :Active bubbling--positive test and No release of bubbles-negative test 
        Coagulase test: This test is used to differentiate S. aureus from other Staphylococcus spp 
Procedure 
1. Place a drop of physiological saline on two separate slides 
2. Emulsify the test organism in each of the drop to make thick suspension 
3. Add one drop of plasma to one of the suspensions and mix gently. Look for clumping of 
the organism within 10 seconds 
4. Interpretation 
         Clumping within 10 seconds ------------------S.aureus 
         No clumping within 10 seconds -------------other staphylococcus species 
Identification of Gram negative bacteria: was based on their test result with a series of 
biochemical tests. 
Procedure 
1. Prepare a suspension of the test organism with nutrient broth. 3-4 colony of test organism 
in 5 ml nutrient broth. 
2. A loop full of the bacterial suspension is inoculated in to indole, citrate agar, triple sugar 
iron agar, lysine decarboxylase agar, Mannitol, urea agar and motility medium. 
3. Incubate at 35-37 OC for 18-24 hours. 
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4. Look for colour change (turbidity for motility) of the medium 
5. Identify the test organism by considering the result of the six biochemical tests 
E. Antimicrobial susceptibility testing 
Procedure 
1. Prepare a suspension of the test organism by emulsifying several colony of the organism 
in a small volume of nutrient broth. 
2. Much the turbidity of suspension with turbidity standard 
3. With a sterile swab take sample from the suspension (squeeze the swab against the side 
of the test tube to remove the excess fluid). 
4. Spread the inoculums evenly over the Muller-Hinton agar plate with the swab 
5. Using a sterile forceps or needle, place the antimicrobial disc on the inoculated plate 
6. Incubate the plate aerobically at 35-37oC for 18-24 hours. 
7. Read the test after checking that the bacterial growth is neither heavy nor light. Measure 
the radius of the inhibition zone. 
8. Interpret the reaction of the test organism to each antibiotics used as sensitive, 
intermediate, or resistance as per the standard Sensitive – zone of radius is wider or 
equal to the control. 
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